Suppr超能文献

设计、合成、生物评价和新的 3-(4,5-二氢-1H-吡唑/异恶唑-5-基)-2-苯基-1H-吲哚衍生物的对接研究作为有效的抗氧化剂和 15-脂氧合酶抑制剂。

Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.

机构信息

Pharmaceutical Chemistry Department, Faculty of Pharmacy, Damanhour University, Damanhour, El-Buhaira, 22516, Egypt.

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, 21526, Egypt.

出版信息

Eur J Med Chem. 2018 Feb 10;145:594-605. doi: 10.1016/j.ejmech.2018.01.026. Epub 2018 Jan 10.

Abstract

New candidates of 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives (4-7) were designed combining the pyrazoline/isoxazoline heterocycles and 2-phenylindole to explore its potential as 15-lipoxygenase (15-LOX) inhibitors. The design of the new derivatives was based on utilizing the antioxidant properties of pyrazoline, 2-phenylindole and the good 15-LOX inhibition properties of indolylpyrazoline. The derivatives were synthesized adopting simple and laboratory friendly reaction conditions to give the target compounds in quantitative yields. The resulting indolylpyrazolines/isoxazolines were evaluated as antioxidants against 2,2-diphenyl-1-picrylhydrazyl (DPPH), nitric oxide (NO) and superoxide dismutase (SOD); indolylpyrazoline (4b) was the most potent antioxidant against SOD assay (IC = 1.78 μM) to be superior to ascorbic by 2 folds. Consistently, (4b) was the most potent inhibitor when tested against Soybean 15-LOX (IC = 3.84 μM) excelling quercetin as standard inhibitor by 1.8 folds. Some of the new derivatives were docked into the active binding site of human 15-LOX (PDB entry 4NRE) emphasizing the most potent derivative (4b) and the least potent one (4c). Docking solutions of compounds (4b), (4c), (5b) and (6c) revealed that (4b) was the only compound that got stabilized into the catalytic pocket of enzyme by π-cation interaction with the catalytic Fe and formation of one hydrogen bond with Ile 676 amino acid. Other derivatives including the least potent one variably got stabilized into the active binding pocket by π-cation interaction with the catalytic Fe but failed to form hydrogen bond with Ile 676. For the future optimization of the generated inhibitors, (i) antioxidant activity against SOD, (ii) the inhibitor stabilization by π-cation interaction with the catalytic Fe and (iii) formation of hydrogen bond with Ile 676 should be regarded.

摘要

新型 3-(4,5-二氢-1H-吡唑/异噁唑-5-基)-2-苯基-1H-吲哚衍生物(4-7)候选物的设计,结合了吡唑啉/异噁唑啉杂环和 2-苯基吲哚,以探索其作为 15-脂氧合酶(15-LOX)抑制剂的潜力。新衍生物的设计基于利用吡唑啉、2-苯基吲哚的抗氧化性质和吲哚基吡唑啉良好的 15-LOX 抑制性质。采用简单且适合实验室的反应条件合成了这些衍生物,以定量产率得到目标化合物。所得的吲哚基吡唑啉/异噁唑啉被评估为 2,2-二苯基-1-苦基肼(DPPH)、一氧化氮(NO)和超氧化物歧化酶(SOD)的抗氧化剂;吲哚基吡唑啉(4b)在 SOD 测定中是最有效的抗氧化剂(IC=1.78µM),比抗坏血酸强 2 倍。一致地,(4b)在测试大豆 15-LOX 时是最强的抑制剂(IC=3.84µM),比标准抑制剂槲皮素强 1.8 倍。一些新的衍生物被对接到人 15-LOX 的活性结合位点(PDB 条目 4NRE),强调最有效的衍生物(4b)和最不有效的衍生物(4c)。化合物(4b)、(4c)、(5b)和(6c)的对接结果表明,(4b)是唯一一种通过与催化铁的π-阳离子相互作用和与 Ile 676 氨基酸形成一个氢键而稳定在酶的催化口袋中的化合物。其他衍生物,包括最不有效的一种,通过与催化铁的π-阳离子相互作用,不同程度地稳定在活性结合口袋中,但未能与 Ile 676 形成氢键。为了进一步优化生成的抑制剂,(i)对 SOD 的抗氧化活性,(ii)与催化铁的π-阳离子相互作用的抑制剂稳定性,以及(iii)与 Ile 676 的氢键形成,都应该被考虑。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验